EcoDrugPlus

Ensembl ID : ENSOMYG00000015216
Gene Symbol: -
Cross references: -
130 Possible Orthologues:

Ensembl ID : ENSOMYG00000007364
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSOMYG00000015616
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSOMYG00000007353
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSOMYG00000015729
Gene Symbol: -
Cross references: -
295 Possible Orthologues:

Ensembl ID : ENSOMYG00000015779
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSOMYG00000007018
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSOMYG00000015921
Gene Symbol: -
Cross references: -
164 Possible Orthologues:

Ensembl ID : ENSOMYG00000016157
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSOMYG00000006978
Gene Symbol: -
Cross references: -
393 Possible Orthologues:

Ensembl ID : ENSOMYG00000016402
Gene Symbol: -
1 Cross references
187 Possible Orthologues:

Ensembl ID : ENSOMYG00000016193
Gene Symbol: -
Cross references: -
990 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).